|
2021
|
Invention
|
Therapeutic agent for frontal lobe dysfunction.
The present invention provides a therapeutic and... |
|
2019
|
Invention
|
Human artificial chromosome containing human antibody lambda light chain gene and non-human anima... |
|
|
Invention
|
Method of producing antibodies with n-glycoside-linked sugar chains lacking fucosylation.
The in... |
|
|
Invention
|
Compound with anticancer activity. A compound with anticancer activity or a pharmaceutically perm... |
|
|
Invention
|
Pharmaceutical composition. The present invention provides a pharmaceutical composition containin... |
|
2018
|
Invention
|
Il-2 variant. αβγαβγαβγ; a method for improving the affinity of IL-2 for IL-2Rα subunit; a method... |
|
|
Invention
|
Anti-bmp10 antibody, and therapeutic agent for hypertension and hypertensive diseases comprising ... |
|
|
Invention
|
Bispecific antibody which binds to cd40 and epcam. The purpose of the present invention is to pro... |
|
|
Invention
|
Hyperphosphatemia treatment agent, and particles. The present invention addresses the problem of ... |
|
|
Invention
|
Hyperphosphatemia treatment agent. The present invention addresses the problem of providing a low... |
|
|
Invention
|
Antibody which specifically binds to human crth2.
There is provided an anti-human CRTH2 antibody... |
|
|
Invention
|
Nucleic-acid-containing lipid nanoparticles. Provided are nucleic-acid-containing lipid nanoparti... |
|
|
Invention
|
Nucleic acid complex. The present invention provides a nucleic acid complex represented by formul... |
|
|
Invention
|
Anti-human ccr1 monoclonal antibody. The present invention addresses the problem of providing a m... |
|
|
Invention
|
Anti-bril antibody and stabilization method of bril fusion protein using said antibody. The purpo... |
|
|
Invention
|
Α, β-unsaturated amide compound. The purpose of the present invention is to provide an α, β-unsat... |
|
|
Invention
|
Nucleic-acid-containing nanoparticles. The present invention pertains to nanoparticles containing... |
|
|
Invention
|
Compound serving as cationic lipid. The present invention provides a compound represented by form... |
|
|
Invention
|
Apcs-expression-suppressing nucleic acids. The present invention provides double-stranded nucleic... |
|
|
Invention
|
Oligonucleotide derivative or salt thereof. The present invention provides: an oligonucleotide de... |
|
|
Invention
|
Polyethylene glycol derivative. Provided is a sustained-release formulation of evocalcet or a pha... |
|
|
Invention
|
Nucleic acid capable of inhibiting expression of masp2. The present invention provides: a nucleic... |
|
|
Invention
|
Production method for darbepoetin composition, and culture method for darbepoetin-producing cells... |
|
|
Invention
|
Preventive or therapeutic agent for htlv-1-associated myelopathy using low-dose anti-ccr4 antibod... |
|
|
Invention
|
Methods of treating patients suffering from movement disorders.
The present invention is direct... |
|
|
Invention
|
Therapeutic or prophylactic agent and treatment or prevention method for radiation sickness. As a... |
|
2017
|
Invention
|
Method for selecting cell.
An object of the present invention is to provide a method for selecti... |
|
|
Invention
|
Method of selecting cells. The purpose of the present invention is to provide a method of selecti... |
|
|
Invention
|
Antibody capable of binding to myelin oligodendrocyte glycoprotein. The present invention relates... |
|
|
Invention
|
Nucleic acid inhibiting expression of complement factor b. Provided are: a nucleic acid having an... |
|
|
Invention
|
Method of treating cancer using anti-ccr4 antibody and anti-pd-1 antibody. A method of treating c... |
|
|
Invention
|
Method for producing aliphatic tertiary amine compound. The present invention provides an efficie... |
|
|
Invention
|
Method for producing pyrrolidine compound. The present invention provides an efficient production... |
|
|
Invention
|
Nucleic-acid-containing lipid nanoparticles. The present invention provides: nucleic-acid-contain... |
|
|
Invention
|
Cationic lipid compound. The present invention provides a compound represented by formula (I), wh... |
|
|
Invention
|
Medicinal composition. The present invention pertains to a therapeutic agent for ophthalmic disea... |
|
|
Invention
|
Medium for culturing stem cells, method for culturing stem cells, stem cell growth promoter, and ... |
|
|
Invention
|
Protein purification method using activated carbon. The purpose of the present invention is to pr... |
|
|
Invention
|
Cationic lipid.
The present invention provides a cationic lipid, which allow nucleic acids to be... |
|
|
Invention
|
Nucleic acid complex. The present invention provides a nucleic acid complex in which a sugar chai... |
|
|
Invention
|
Method for producing pharmaceutical composition containing microparticles of sparingly-soluble dr... |
|
|
Invention
|
Nucleic acid capable of inhibiting expression of beta-2gpi.
The present invention provides a nuc... |
|
|
Invention
|
Human common monocyte progenitors capable of differentiating exclusively into monocytic cells and... |
|
|
Invention
|
Autoimmune disease therapeutic agent containing, as active ingredient, antibody that binds to hap... |
|
|
Invention
|
Liquid pharmaceutical composition containing darbepoetin. The purpose of the present invention is... |
|
2016
|
Invention
|
ß2gpi gene expression-suppressing nucleic acid conjugate.
The present invention provides a nucle... |
|
|
Invention
|
Antisense oligonucleotide inhibiting ß2gpi expression.
The present invention aims to provide a n... |
|
|
Invention
|
Oligonucleotide derivative.
The present invention provides an oligonucleotide derivative having,... |
|
|
Invention
|
Bispecific antibody binding to trailr2 and psma.
The present invention is related to a bispecifi... |
|
2015
|
G/S
|
Industrial chemicals; chemicals for use in the manufacture
of dietary supplements and foods; che... |
